Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Paradiso

Showing results (51-60 of 191) with videos related to

Pageof 20
Sort By:
Molecular Biotechnology|January 2, 2013
Molecular profiling of thin-prep FNA samples in assisting clinical management of non-small-cell lung cancerDaniela Petriella, Domenico Galetta, Vincenza Rubini, et al.
Current Drug Metabolism|July 27, 2011
The impact of folate status on the efficacy of colorectal cancer treatmentLetizia Porcelli, Yehuda G Assaraf, Amalia Azzariti, et al.
Tumori|October 30, 2004
Analysis of the reasons for accepting or declining participation in genetic research for breast cancer: a hospital-based population studyAngelo Paradiso, Michele Bruno, Onofrio Cicoria, et al.
Cancer Genetics and Cytogenetics|April 15, 2008
Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancersAnita Mangia, Patrizia Chiarappa, Stefania Tommasi, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 12, 2020
Oncological genetic counseling (OGC) for high-risk hereditary cancer: what can hospital anxiety and depression scale (HADs) tell us?Silvia Costanzo, Claudia Cormio, Francesca Romito, et al.
BMC Cancer|December 19, 2006
Phase II trial of sequential gefitinib after minor response or partial response to chemotherapy in Chinese patients with advanced non-small-cell lung cancerJian Ming Xu, Yu Han, Yue Min Li, et al.
Critical Reviews in Oncology/Hematology|June 24, 2009
Clinical relevance of contrast-enhanced ultrasound in monitoring anti-angiogenic therapy of cancer: current status and perspectivesMichele Lamuraglia, S Lori Bridal, Mathieu Santin, et al.
Anticancer Research|January 4, 2012
Circulating transforming growth factor-β and epidermal growth factor receptor as related to virus infection in liver carcinogenesisRosa Divella, Antonella Daniele, Cosimo Gadaleta, et al.
International Journal of Oncology|November 14, 2002
Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinomaGirolamo Ranieri, Angela Labriola, Gaetano Achille, et al.
Molecular Biotechnology|November 11, 2011
DHPLC/SURVEYOR nuclease: a sensitive, rapid and affordable method to analyze BRCA1 and BRCA2 mutations in breast cancer familiesBrunella Pilato, Simona De Summa, Katia Danza, et al.
Pageof 20

Showing results (51-60 of 191) with videos related to

Sort By:
Pageof 20
Molecular Biotechnology|January 2, 2013
Molecular profiling of thin-prep FNA samples in assisting clinical management of non-small-cell lung cancerDaniela Petriella, Domenico Galetta, Vincenza Rubini, et al.
Current Drug Metabolism|July 27, 2011
The impact of folate status on the efficacy of colorectal cancer treatmentLetizia Porcelli, Yehuda G Assaraf, Amalia Azzariti, et al.
Tumori|October 30, 2004
Analysis of the reasons for accepting or declining participation in genetic research for breast cancer: a hospital-based population studyAngelo Paradiso, Michele Bruno, Onofrio Cicoria, et al.
Cancer Genetics and Cytogenetics|April 15, 2008
Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancersAnita Mangia, Patrizia Chiarappa, Stefania Tommasi, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|April 12, 2020
Oncological genetic counseling (OGC) for high-risk hereditary cancer: what can hospital anxiety and depression scale (HADs) tell us?Silvia Costanzo, Claudia Cormio, Francesca Romito, et al.
BMC Cancer|December 19, 2006
Phase II trial of sequential gefitinib after minor response or partial response to chemotherapy in Chinese patients with advanced non-small-cell lung cancerJian Ming Xu, Yu Han, Yue Min Li, et al.
Critical Reviews in Oncology/Hematology|June 24, 2009
Clinical relevance of contrast-enhanced ultrasound in monitoring anti-angiogenic therapy of cancer: current status and perspectivesMichele Lamuraglia, S Lori Bridal, Mathieu Santin, et al.
Anticancer Research|January 4, 2012
Circulating transforming growth factor-β and epidermal growth factor receptor as related to virus infection in liver carcinogenesisRosa Divella, Antonella Daniele, Cosimo Gadaleta, et al.
International Journal of Oncology|November 14, 2002
Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinomaGirolamo Ranieri, Angela Labriola, Gaetano Achille, et al.
Molecular Biotechnology|November 11, 2011
DHPLC/SURVEYOR nuclease: a sensitive, rapid and affordable method to analyze BRCA1 and BRCA2 mutations in breast cancer familiesBrunella Pilato, Simona De Summa, Katia Danza, et al.
Pageof 20